Omega Diagnostics breaks silence and is confident in DHSC deal

Omega Diagnostics has broken its relative recent silence by updating investors with a string of positive news and prospects.

In an update, the diagnostics specialist revealed five areas of current and prospective opportunity for the business, but the update which arguably ‘stole the show’ was the fact its still in talks with third parties introduced by the DHSC to produce a suitable antigen lateral flow test.

With a potential contract award of £374m budgeted by the DHSC, investors will continue to hope that the expectations turn into a reality.

Crucially, Omega Diagnostics added that it is ‘optimistic’ that talks will reach a successful outcome as it ends up supplying the DHSC with a suitable test manufactured using its supply capacity.

The flurry of news came via its social media account following a recovery in share price as investors anticipated a string of good news to come and decided to buy Omega Diagnostics shares as shares in Abingdon Health saw a storming recovery.

The five updates from Omega Diagnostics

Daily Movers

Let's Talk

Buying Abingdon Health shares - w …Great interview - thanks. Prospects look good and not definitely n … Read More
Holding or selling ODX shares? Pr …That update looks like it saved it up from 40p! Would look foolish … Read More
Does Aquis do RNS announcements£270 per announcement that's mad!??! Would definitely make se … Read More
Buying Tremor SharesNot the end of the world; £8 now so not the best short term gain Read More
BOTB share price target at £14 - …Haven't seen the report but suppose if they invest wisely and … Read More
Hey, profit awaits! Free Sharebuyers Newsletter

Receive hot tips you can profit from - only sent when it matters. Twitter: @ShareBuyers.